As part of Genpharm/Genzyme commitment to support and expand MS research across the Middle East & North Africa region, it’s our pleasure to announce the launch of ASPIRE Grant during the 1st MENACTRIMS meeting in October 2014.
The aim of this Annual scientific grant is to support regional research ideas by academic & clinical researchers to enhance our understanding of multiple sclerosis in the MENA patient population and to help improve the quality of life of MS patients.
Potential research areas that will be funded through the ASPIRE Grant will include; MS risk factors, epidemiology, natural history and other relevant topics to clinical practice in the MENA region.
The ASPIRE Grant is exclusively funded by Genpharm/Genzyme.
For more information on the eligibility criteria and the blinded application process kindly click on www.aspiremsgrant.com
For any enquiries you can contact us at email@example.com